RU93058535A - TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT - Google Patents

TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT

Info

Publication number
RU93058535A
RU93058535A RU93058535/14A RU93058535A RU93058535A RU 93058535 A RU93058535 A RU 93058535A RU 93058535/14 A RU93058535/14 A RU 93058535/14A RU 93058535 A RU93058535 A RU 93058535A RU 93058535 A RU93058535 A RU 93058535A
Authority
RU
Russia
Prior art keywords
kolestipol
hydrochloride
producing
tablet containing
new
Prior art date
Application number
RU93058535/14A
Other languages
Russian (ru)
Other versions
RU2108090C1 (en
Inventor
Вью-вей Шен Роберт
Эллис Прайс Джеффри
Original Assignee
Дзе Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Апджон Компани filed Critical Дзе Апджон Компани
Priority claimed from PCT/US1992/005066 external-priority patent/WO1993000915A1/en
Publication of RU93058535A publication Critical patent/RU93058535A/en
Application granted granted Critical
Publication of RU2108090C1 publication Critical patent/RU2108090C1/en

Links

Claims (1)

Настоящее изобретение обеспечивает новую композицию вещества и новый способ его приготовления. В частности, изобретение обеспечивает уникальные и новые 1000 мг - таблетки гидрохлорида колестипола, имеющие полезные свойства твердости и малой хрупкости и новый способ приготовления таких таблеток.The present invention provides a new composition of the substance and a new method for its preparation. In particular, the invention provides unique and new 1000 mg colestipol hydrochloride tablets having useful hardness and low brittleness properties and a new method for preparing such tablets.
RU93058535A 1991-07-03 1992-06-23 Tablet containing cholesterol hydrochloride and method for its production RU2108090C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
US07/725044 1991-07-03
US07/725,044 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (2)

Publication Number Publication Date
RU93058535A true RU93058535A (en) 1996-09-20
RU2108090C1 RU2108090C1 (en) 1998-04-10

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93058535A RU2108090C1 (en) 1991-07-03 1992-06-23 Tablet containing cholesterol hydrochloride and method for its production

Country Status (18)

Country Link
US (1) US5490987A (en)
EP (1) EP0592594B1 (en)
JP (1) JP3313710B2 (en)
KR (1) KR100240362B1 (en)
AT (1) ATE173931T1 (en)
AU (1) AU669664B2 (en)
CA (1) CA2110166C (en)
CZ (1) CZ286958B6 (en)
DE (1) DE69227773T2 (en)
DK (1) DK0592594T3 (en)
ES (1) ES2124736T3 (en)
FI (1) FI106843B (en)
HU (1) HU222242B1 (en)
NO (1) NO307686B1 (en)
PL (1) PL169045B1 (en)
RU (1) RU2108090C1 (en)
SK (1) SK281920B6 (en)
WO (1) WO1993000915A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
BRPI0015061B8 (en) * 1999-10-19 2021-05-25 Geltex Pharma Inc coated tablet having high dosage of sevelamer hydrochloride
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
WO2005065291A2 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2009507019A (en) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション Method for removing phosphate and polymer used therein
CN101272762B (en) 2005-09-15 2013-02-06 基酶有限公司 Sachet formulation for amine polymers
WO2008062437A2 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
BRPI0720234A2 (en) 2006-12-14 2013-12-24 Genzyme Corp PHARMACEUTICAL COMPOSITION
KR20110059750A (en) * 2008-09-02 2011-06-03 유에스브이 리미티드 Crosslinked polymers
KR20110119714A (en) * 2009-01-22 2011-11-02 유에스브이 리미티드 Pharmaceutical compositions comprising phosphate-binding polymer
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (en) 2014-12-18 2017-10-24 Genzyme Corp CROSS-LINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
JPH0764738B2 (en) * 1988-06-24 1995-07-12 ジ・アップジョン・カンパニー Method for producing finely ground colestipol hydrochloride
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
EP0429541B1 (en) * 1988-08-26 1993-12-01 The Upjohn Company Fine-beaded colestipol hydrochloride

Similar Documents

Publication Publication Date Title
RU93058535A (en) TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT
HUT59306A (en) Process for producing pharmaceutical compositions comprising l-carnitine
HUP9800417A3 (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-indoles and 5-substituted-3-(piperidin-4-yl)-1h-indoles, their use as new 5-ht agonists, pharmaceutical compositions containing these compounds
GR3032732T3 (en) Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them.
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
SE9704545D0 (en) Novel compounds
SE9704544D0 (en) Novel compounds
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
CA2054752A1 (en) Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
CA2056066A1 (en) A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it
CA2348086A1 (en) Controlled-release pharmaceutical formulations
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
CA2110166A1 (en) Tableting of colestipol hydrochloride
FR2669932B1 (en) NOVEL HEPAROSANE-N, O-SULFATE, ITS PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
CA2001572A1 (en) Compositions for treating tobacco withdrawal symptoms
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
DE69907926D1 (en) 1,2,4-TRIAZOL-3-THION COMPOUNDS
IT1230795B (en) PROCEDURE FOR PREPARING 1,1,1,2 TETRAFLUOROETHANE FROM 1,1 DICHLOR 1,2,2,2 TETRAFLUOROETHANE.
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
IT1230780B (en) PROCEDURE FOR THE PREPARATION OF 1,2 DICHLOR 1,1,2 TRIFLUOROETHANE.
CA2066532A1 (en) Pharmaceutical compositions
CA2002182A1 (en) Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use
AU5194190A (en) Magnesium folates, process for their preparation and pharmaceutical compositions
AU632313B2 (en) New platinum complexes, their preparation and pharmaceutical compositions which contain them